Dr. Parker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
20 York St
Yale-New Haven Hospital
New Haven, CT 06510Phone+1 203-200-4363Fax+1 203-785-4116- Is this information wrong?
Summary
- Dr. Terri Parker is an oncologist in New Haven, CT and is affiliated with Yale-New Haven Hospital. She received her medical degree from St. George's University School of Medicine and has been in practice 12 years. She specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, and multiple myeloma.
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- Uconn School Of Medicine2008 - 2009
- University of ConnecticutResidency, Internal Medicine, 2005 - 2008
- St. George's University School of MedicineClass of 2005
Certifications & Licensure
- CT State Medical License 2008 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- David S. Fischer Teaching Award for Outstanding Faculty Teaching and Mentoring of Fellows in Medical Oncology Yale Cancer Center, 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma Start of enrollment: 2012 Nov 01
- Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2013 Dec 06
- An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma Start of enrollment: 2016 Aug 10
- Join now to see all
Publications & Presentations
PubMed
- Peripheral Blasts in a Patient Receiving Chemotherapy.Sabin Kshattry, Terri L Parker, Scott F Huntington> ;JAMA. 2023 Oct 24
- Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma.Facon T, Kumar S, Plesner T, Orlowski RZ, Moreau P, Bahlis N, Basu S, Nahi H, Hulin C, Quach H, Goldschmidt H, O'Dwyer M, Perrot A, Venner CP, Weisel K, Mace JR, Raje ...> ;The New England journal of medicine.
- 1 citationsCost-effectiveness of once-weekly selinexor, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma.Kishan Patel, Terri L. Parker, Mengyang Di, Noffar Bar, Scott F. Huntington, Smith Giri> ;Leukemia & Lymphoma. 2021 Jun 21
- Join now to see all
Abstracts/Posters
- Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacy...Terri L Parker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center ExperienceTerri L Parker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Cutaneous toxicity of pralatrexate in cutaneous and peripheral T-cell lymphomaParker TL, Barbarotta L, Girardi M, and Foss F., American Society of Hematology Annual Meeting, Atlanta, GA, 12/2012
Committees
- Member, Scientific Protocol Review Committee at Smilow Cancer Hospital 2015 - Present
- Member, Laboratory Formulary Committee at Yale New Haven Hospital 2014 - Present
- Member, Smilow Ambulatory Care Committee 2013 - Present
- Member, Transfusion and Tissue Banking Committee at Yale New Haven Hospital 2013 - Present
- Member, Faculty Advisory Committee at Yale School of Medicine 2015 - 2017
Professional Memberships
- Member
- Member
- Member
- International Society of AmyloidosisMember
- International Myeloma SocietyMember
Hospital Affiliations
- Yale-New Haven HospitalNew Haven, Connecticut
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: